DOMINGO VILLARREAL: Open Payments
NPI 1548912199 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,277 in 111 payments from 17 companies in 2025. Trend: 2023 $1,128 · 2024 $2,462 · 2025 $2,277
Food & beverage: $2,217Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $523 |
| Lilly USA, LLC | 11 | $396 |
| AstraZeneca Pharmaceuticals LP | 12 | $227 |
| Novo Nordisk Inc | 13 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $173 |
| PFIZER INC. | 17 | $171 |
| Axsome Therapeutics, Inc. | 8 | $136 |
| Astellas Pharma US Inc | 3 | $98 |
| Exact Sciences Corporation | 4 | $75 |
| GlaxoSmithKline, LLC. | 4 | $60 |
Products named: VRAYLAR, JARDIANCE, Kerendia, NURTEC ODT, QULIPTA, KISUNLA, Auvelity, Wegovy.
Industry payments across TX — which companies pay providers there.
